Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)

Clinical and Translational Oncology

Volumn 11, Issue 7, 2009, Pages 486-487

  Henarejos, Pilar Sánchez ^a   Martínez, Silverio Ros ^a   Marín Zafra, Gema R ^a   Alonso Romero, José L ^a   Montoya, Agustín Navarrete ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Anthracyclines; Breast carcinoma; Dermatologic toxicity; Liposomes

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG DERIVATIVE; MACROGOL DERIVATIVE;

ADULT; ARTICLE; BREAST TUMOR; CANCER STAGING; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; FEMALE; HUMAN; INTERTRIGO; METASTASIS; PATHOLOGY; TUMOR RECURRENCE;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; DOXORUBICIN; DRUG ERUPTIONS; FEMALE; HUMANS; INTERTRIGO; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYETHYLENE GLYCOLS;

EID: 73349084306     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-009-0390-2     Document Type: Article

References (5)

1. Aimee SP, William DJ, Raymond BW (2006) Dermatologic toxicity of chemotherapeutic agents. Semin Oncol 33:86-97
2. Lotem M, Hubert A, Lyass O et al (2000) Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol 136:1475-1480
3. Lyass O, Uziely B, Ben-Yosef R et al (2000) Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer 89:1037-1047
4. English JC 3rd, Toney R, Patterson JW (2003) Intertriginous epidermal dysmaturation from pegylated liposomal doxorubicin. J Cutan Pathol 30:591-595
5. Korac B, Buzadzic B (2001) Doxorubicin toxicity to the skin: Possibility of protection with antioxidants enriched yeast. J Dermatol Sci 25:45-52